Dr. Lim is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
One Health Plaza
East Hanover, NJ 07936Phone+1 862-579-6021
Summary
- Dr. Stephen Lim is a senior medical director for Novartis the CAR-T program. He completed his fellowships in Hematology and Medical Oncology at UCLA David Geffen School of Medicine/UCLA Medical Center and Los Angeles County-Harbor-UCLA Medical Center.
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1993 - 1995
- Los Angeles County-Harbor-UCLA Medical Center 1Fellowship, Hematology and Medical Oncology, 1992 - 1993
- Los Angeles County-Harbor-UCLA Medical CenterResidency, Internal Medicine, 1989 - 1992
- David Geffen School of Medicine at UCLAClass of 1989
Certifications & Licensure
- CA State Medical License 1990 - 2026
Publications & Presentations
PubMed
- 4 citationsA phase 2 trial of the efficacy and safety of elotuzumab in combination with pomalidomide, carfilzomib and dexamethasone for high-risk relapsed/refractory multiple mye...David Yashar, Tanya M. Spektor, Daisy Martinez, Matthew Ghermezi, Regina A. Swift
Leukemia & Lymphoma. 2021-11-24 - 25 citationsA Phase I Study of Ruxolitinib, Lenalidomide, and Steroids for Patients with Relapsed/Refractory Multiple Myeloma.James R. Berenson, Jennifer To, Tanya M. Spektor, Daisy Martinez, Carley Turner
Clinical Cancer Research. 2020-05-15 - 57 citationsProlactinoma ErbB receptor expression and targeted therapy for aggressive tumors.Odelia Cooper, Adam N. Mamelak, Serguei Bannykh, John D. Carmichael, Vivien Bonert
Endocrine. 2014-06-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: